PL EN


2008 | 6 | 1-2 |
Article title

The impact of protection of the intellectual property rights on the pharmaceutical market in India

Content
Title variants
Languages of publication
EN
Abstracts
PL
India is struggling not only against communicable diseases but also carries a large burden of non-communicable diseases. India is one of the 10 countries hosting 75% of the children who had not received vaccines for vaccine preventable diseases, like diphtheria, pertusis and tetanus. The diseases caused by Haemophilus, Pneumococcus and Rotaviruses, which are causing 2.1 million deaths in all age groups worldwide, have not even nudged the Indian government to provide access to the appropriate vaccines. For the pharmaceutical industry, R&D (research & development) on vaccines is not that profitable as the purchases are made by the government and moreover, the use is only for one time. There is a lack of vaccine coverage in the developing world and there is a growing need for developing new and better vaccines.
Year
Volume
6
Issue
1-2
Physical description
Dates
published
2008
online
2008-02-25
References
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.ojs-issn-2084-2627-year-2008-volume-6-issue-1-2-article-5863
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.